skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

25 Total results for product and free and sample content found

Scrip: 世界の医療用医薬品&製薬産業に関するニュース, Datamonitor He...

Top 10 Best-Selling Drugs of 2019

In 2019, the 10 most lucrative medicines generated combined global sales of $92.5B. Scrip provides insight into these top sellers and the companies behind them, as well US dynamics, global sales forecasts and lifecycle data, with complementary market analysis from Datamonitor Healthcare on diseases targeted, indications, and more.

Topic Drug Review Diseases

Rare Congenital and Genetic Diseases Strategy Solutions

Rare Congenital and Genetic Diseases Strategy Solutions

Gain Clarity of Sight into What Comes Next with Citeline According to Informa’s Pharmaprojects, less than 3% of all rare congenital and genetic diseases have an approved therapy. Opportunities abound ­if you know the risks. Make better strategic and planning decisions with Intelligence services that give you a clear line of sight, helping you maximize clinical and commercial opportunities, navigate uncertainties, and ensure more successful outcomes. 

Topic diseases

Informatics Solutions

Discover the power of Pharma360

Streamline your workflow with a new solution that delivers critical disease overviews back to you quickly, easily, and efficiently with the new Pharma360.

Topic diseases

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

NASH Disease Coverage Extract

NASH Disease Coverage Extract

Datamonitor Healthcare recently surveyed 60 gastroenterologists in the US and five major EU markets after the approval of the first disease-specific therapies for the treatment of non-alcoholic steatohepatitis (NASH). The market for these treatments will exceed $21bn in 2027.   

Topic Drug development landscape Diseases

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

Could The Gut Cure Brain Disease?

Could The Gut Cure Brain Disease?

Scientists now understand that there are multiple, bi-directional links between gut and brain. They are using this knowledge to develop new treatments for some of the most challenging chronic conditions, including Alzheimer’s disease, Parkinson’s disease and obesity.

Topic diseases

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Finance Watch: Alternative Funding Sources Crucial Even Amidst A Biopharma VC Boom

Finance Watch: Alternative Funding Sources Crucial Even Amidst A Biopharma VC Boom

Private Company Edition: Investments by CIRM, the GHIT fund and the European Investment Bank back early-stage science and treatments for neglected diseases. Also, Versant Ventures raises $700m in two funds. In VC deals, Akero raised $70m, Impel NeuroPharma brought in $67.5m.

Topic diseases

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

World AIDS Day 2018 GlaxoSmithKline report

World AIDS Day 2018 GlaxoSmithKline report

PharmaVitae explores GlaxoSmithKline’s prescription pharmaceutical performance and outlook over 2017–27. PharmaVitae analyses include quarterly earnings coverage and provide timely updates to company product forecasts. The full company profile encompasses analysis on corporate strategy, portfolio analysis, pipeline potential, and financial performance.

Topic Diseases Drug development landscape Drug review

Pharmaprojects: 医薬品開発パイプラインのデータベース

Pharma R&D Annual Review 2019

 Pharma R&D Annual Review 2019

Pharma R&D Annual Review 2019 is based on the stats and data from from Pharmaprojects, part of Informa’s Citeline family of intelligence solutions. Authored for the 27th time by Ian Lloyd, Senior Director, Pharmaprojects.

Topic clinical-trials diseases research drug-approval drug-review

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。